pubmed-article:15781025 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15781025 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15781025 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:15781025 | lifeskim:mentions | umls-concept:C0370231 | lld:lifeskim |
pubmed-article:15781025 | lifeskim:mentions | umls-concept:C0028351 | lld:lifeskim |
pubmed-article:15781025 | lifeskim:mentions | umls-concept:C0034785 | lld:lifeskim |
pubmed-article:15781025 | lifeskim:mentions | umls-concept:C0022245 | lld:lifeskim |
pubmed-article:15781025 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:15781025 | lifeskim:mentions | umls-concept:C0264716 | lld:lifeskim |
pubmed-article:15781025 | lifeskim:mentions | umls-concept:C1819464 | lld:lifeskim |
pubmed-article:15781025 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:15781025 | pubmed:dateCreated | 2005-3-22 | lld:pubmed |
pubmed-article:15781025 | pubmed:abstractText | Increased levels of tumor necrosis factor-alpha (TNF-alpha) correlate with poor prognoses in chronic heart failure (CHF). This study demonstrated that noradrenaline and isoproterenol inhibit TNF-alpha production in patients with CHF in ex vivo whole blood in a dose-dependent fashion. The beta-blocker bisoprolol abolishes this effect. | lld:pubmed |
pubmed-article:15781025 | pubmed:language | eng | lld:pubmed |
pubmed-article:15781025 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15781025 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15781025 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15781025 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15781025 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15781025 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15781025 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15781025 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15781025 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15781025 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15781025 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15781025 | pubmed:month | Apr | lld:pubmed |
pubmed-article:15781025 | pubmed:issn | 0002-9149 | lld:pubmed |
pubmed-article:15781025 | pubmed:author | pubmed-author:DietzRainerR | lld:pubmed |
pubmed-article:15781025 | pubmed:author | pubmed-author:KempMichaelM | lld:pubmed |
pubmed-article:15781025 | pubmed:author | pubmed-author:AnkerStefan... | lld:pubmed |
pubmed-article:15781025 | pubmed:author | pubmed-author:KalraPaul RPR | lld:pubmed |
pubmed-article:15781025 | pubmed:author | pubmed-author:AdcockIan MIM | lld:pubmed |
pubmed-article:15781025 | pubmed:author | pubmed-author:Poole-WilsonP... | lld:pubmed |
pubmed-article:15781025 | pubmed:author | pubmed-author:BolgerAidan... | lld:pubmed |
pubmed-article:15781025 | pubmed:author | pubmed-author:von... | lld:pubmed |
pubmed-article:15781025 | pubmed:author | pubmed-author:Genth-ZotzSab... | lld:pubmed |
pubmed-article:15781025 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15781025 | pubmed:day | 1 | lld:pubmed |
pubmed-article:15781025 | pubmed:volume | 95 | lld:pubmed |
pubmed-article:15781025 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15781025 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15781025 | pubmed:pagination | 885-9 | lld:pubmed |
pubmed-article:15781025 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:meshHeading | pubmed-meshheading:15781025... | lld:pubmed |
pubmed-article:15781025 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15781025 | pubmed:articleTitle | Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors. | lld:pubmed |
pubmed-article:15781025 | pubmed:affiliation | Department of Clinical Cardiology, National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom. stephan.von.haehling@web.de | lld:pubmed |
pubmed-article:15781025 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15781025 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15781025 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15781025 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15781025 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15781025 | lld:pubmed |